Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priya Abraham

Showing results (161-170 of 191) with videos related to

Pageof 20
Sort By:
Journal of Medical Virology|July 31, 2021
Performance assessment of seven SARS-CoV-2 IgG enzyme-linked immunosorbent assaysKetki Deshpande, Ullas Pt, Ojas Kaduskar, et al.
Journal of Travel Medicine|March 4, 2022
Immune responses against different variants of SARS-CoV-2 including Omicron following 6 months of administration of heterologous prime-boost COVID-19 vaccineGajanan Sapkal, Rajni Kant, Gaurav Dwivedi, et al.
Journal of Medical Virology|May 15, 2023
An imported case of fatal encephalitis associated with mpox virus infection, India, July 2022Pragya D Yadav, Meenakshy Vasu, Fazil Abubaker, et al.
BMJ Open|December 30, 2025
Protocol for a cervical screening implementation trial comparing two approaches for delivering HPV self-collection in low-resource settings in India: a type 3 hybrid cluster randomised controlled trial (SHE-CAN)Anu Mary Oommen, Maleeha Ashfaq, Mary Vanlalhruaii Tonsing, et al.
Scientific Reports|July 14, 2022
Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variantsKrishna Mohan Vadrevu, Brunda Ganneru, Siddharth Reddy, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 20, 2021
Longitudinal clinico-serological analysis of anti-nucleocapsid and anti-receptor binding domain of spike protein antibodies against SARS-CoV-2Gururaj Rao Deshpande, Ojas Kaduskar, Ketki Deshpande, et al.
Human Vaccines & Immunotherapeutics|December 28, 2022
Evaluation of immunogenicity post two doses of inactivated SARS-CoV-2 vaccine, Covaxin after six monthsRima R Sahay, Pragya D Yadav, Ashok Nandapurkar, et al.
Journal of Infection and Public Health|November 6, 2025
Persistence of post-acute COVID-19 sequelae up to four years in patients with long COVID from Western India: A cross-sectional descriptive studyMadhu C Mohanty, Ketki S Jawade, Sushmita S Rane, et al.
The Indian Journal of Medical Research|July 3, 2020
Evaluation of the susceptibility of mice & hamsters to SARS-CoV-2 infectionSreelekshmy Mohandas, Rajlaxmi Jain, Pragya D Yadav, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 5, 2010
Region-wise distribution of high-risk human papillomavirus types in squamous cell carcinomas of the cervix in IndiaRadhakrishna M Pillai, Janaki M Babu, Vinoda T Jissa, et al.
Pageof 20

Showing results (161-170 of 191) with videos related to

Sort By:
Pageof 20
Journal of Medical Virology|July 31, 2021
Performance assessment of seven SARS-CoV-2 IgG enzyme-linked immunosorbent assaysKetki Deshpande, Ullas Pt, Ojas Kaduskar, et al.
Journal of Travel Medicine|March 4, 2022
Immune responses against different variants of SARS-CoV-2 including Omicron following 6 months of administration of heterologous prime-boost COVID-19 vaccineGajanan Sapkal, Rajni Kant, Gaurav Dwivedi, et al.
Journal of Medical Virology|May 15, 2023
An imported case of fatal encephalitis associated with mpox virus infection, India, July 2022Pragya D Yadav, Meenakshy Vasu, Fazil Abubaker, et al.
BMJ Open|December 30, 2025
Protocol for a cervical screening implementation trial comparing two approaches for delivering HPV self-collection in low-resource settings in India: a type 3 hybrid cluster randomised controlled trial (SHE-CAN)Anu Mary Oommen, Maleeha Ashfaq, Mary Vanlalhruaii Tonsing, et al.
Scientific Reports|July 14, 2022
Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variantsKrishna Mohan Vadrevu, Brunda Ganneru, Siddharth Reddy, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 20, 2021
Longitudinal clinico-serological analysis of anti-nucleocapsid and anti-receptor binding domain of spike protein antibodies against SARS-CoV-2Gururaj Rao Deshpande, Ojas Kaduskar, Ketki Deshpande, et al.
Human Vaccines & Immunotherapeutics|December 28, 2022
Evaluation of immunogenicity post two doses of inactivated SARS-CoV-2 vaccine, Covaxin after six monthsRima R Sahay, Pragya D Yadav, Ashok Nandapurkar, et al.
Journal of Infection and Public Health|November 6, 2025
Persistence of post-acute COVID-19 sequelae up to four years in patients with long COVID from Western India: A cross-sectional descriptive studyMadhu C Mohanty, Ketki S Jawade, Sushmita S Rane, et al.
The Indian Journal of Medical Research|July 3, 2020
Evaluation of the susceptibility of mice & hamsters to SARS-CoV-2 infectionSreelekshmy Mohandas, Rajlaxmi Jain, Pragya D Yadav, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 5, 2010
Region-wise distribution of high-risk human papillomavirus types in squamous cell carcinomas of the cervix in IndiaRadhakrishna M Pillai, Janaki M Babu, Vinoda T Jissa, et al.
Pageof 20